The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, R.
Right arrow Articles by Hori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, R.
Right arrow Articles by Hori, T.
The Journal of Immunology, 2005, 175: 806-812.
Copyright © 2005 by The American Association of Immunologists

Nitric Oxide Inhibits IFN-{alpha} Production of Human Plasmacytoid Dendritic Cells Partly via a Guanosine 3',5'-Cyclic Monophosphate-Dependent Pathway1

Rimpei Morita2,*,{dagger}, Takashi Uchiyama* and Toshiyuki Hori3,*

* Department of Hematology and Oncology and{dagger} Horizontal Medical Research Organization, Graduate School of Medicine, Kyoto University, Kyoto, Japan

NO, a free radical gas, is known to be critically involved not only in vascular relaxation but also in host defense. Besides direct bactericidal effects, NO has been shown to inhibit Th1 responses and modulate immune responses in vivo, although the precise mechanism is unclear. In this study, we examined the effect of NO on human plasmacytoid dendritic cells (pDCs) to explore the possibility that NO might affect innate as well as adaptive immunity through pDCs. We found that NO suppressed IFN-{alpha} production of pDCs partly via a cGMP-dependent mechanism, which was accompanied by down-regulation of IFN regulatory factor 7 expression. Furthermore, treatment of pDCs with NO decreased production of IL-6 and TNF-{alpha} and up-regulated OX40 ligand expression. In accordance with these changes, pDCs treated with NO plus CpG-oligodeoxynucleotide AAC-30 promoted differentiation of naive CD4+ T cells into a Th2 phenotype. Moreover, pDCs did not express inducible NO synthase even after treatment with AAC-30, LPS, and several cytokines. These results suggest that exogenous NO and its second messenger, cGMP, alter innate as well as adaptive immune response through modulating the functions of pDCs and may be involved in the pathogenesis of certain Th2-dominant allergic diseases.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Ha, J.-H. Lee, H.-N. Kim, H. B. Kwak, H.-M. Kim, S. E. Lee, J. H. Rhee, H.-H. Kim, and Z. H. Lee
Stimulation by TLR5 Modulates Osteoclast Differentiation through STAT1/IFN-{beta}
J. Immunol., February 1, 2008; 180(3): 1382 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Integr. Comp. Biol.Home page
E. Spinelli Oliveira, J. T. Hancock, M. Hermes-Lima, D. A. Isola, M. Ochs, J. Yu, and D. Wilhem Filho
Implications of dealing with airborne substances and reactive oxygen species: what mammalian lungs, animals, and plants have to say?
Integr. Comp. Biol., October 1, 2007; 47(4): 578 - 591.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Plskova, K. Greiner, E. Muckersie, L. Duncan, and J. V. Forrester
Interferon-{alpha}: A Key Factor in Autoimmune Disease?
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3946 - 3950.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.